In vitro development of resistance to newer fluoroquinolones in Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin

Eur J Clin Microbiol Infect Dis. 2001 Apr;20(4):288-91. doi: 10.1007/pl00011267.

Authors

S Mayer¹, M Boos, K Köhrer, A C Fluit, F J Schmitz

Affiliation

¹ Institute for Medical Microbiology and Virology, Heinrich-Heine Universität Düsseldorf, Germany.

PMID: 11399024
DOI: 10.1007/pl00011267

No abstract available

MeSH terms

Anti-Infective Agents / pharmacology*
Ciprofloxacin / pharmacology*
DNA Gyrase
DNA Topoisomerase IV
DNA Topoisomerases, Type II / metabolism
Drug Resistance, Microbial
Humans
Microbial Sensitivity Tests
Streptococcus pneumoniae / drug effects*
Streptococcus pneumoniae / enzymology

Substances

Anti-Infective Agents
Ciprofloxacin
DNA Topoisomerase IV
DNA Gyrase
DNA Topoisomerases, Type II